Comments on 'competing designs for drug combination in phase I dose-finding clinical trials' by M-K. Riviere, F. Dubois, S. Zohar

Stat Med. 2015 Jan 15;34(1):18-22. doi: 10.1002/sim.6336.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Clinical Trials, Phase I as Topic / methods*
  • Dose-Response Relationship, Drug*
  • Drug Combinations*
  • Humans
  • Maximum Tolerated Dose*

Substances

  • Antineoplastic Agents
  • Drug Combinations